文摘
Retrospective study of pre-emptive immunotherapy in childhood acute lymphoblastic leukemia after transplantation Additional data for close monitoring of chimerism and minimal residual disease for detection of a high risk of relapse Stop of immunosuppression and unmanipulated donor lymphocyte infusion is safe, feasible, and effective Approach for preventing relapse in acute lymphoblastic leukemia patients at risk Close monitoring and immunotherapy result in similar outcome for patients with and without molecular relapse after transplantation